Gene: Slamf1 (signaling lymphocytic activation molecule family member 1) Rattus norvegicus
Analyze
Symbol: Slamf1
Name: signaling lymphocytic activation molecule family member 1
Description: Predicted to have identical protein binding activity and signaling receptor activity; predicted to be involved in several processes, including natural killer cell activation, negative regulation of cytokine production, and regulation of signal transduction; predicted to localize to the external side of plasma membrane and phagocytic vesicle; orthologous to human SLAMF1 (signaling lymphocytic activation molecule family member 1); PARTICIPATES IN measles pathway; INTERACTS WITH (RS)-amphetamine; 2,2',4,4'-Tetrabromodiphenyl ether; 6-propyl-2-thiouracil.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: LOC498286; RGD1560634; signaling lymphocytic activation molecule; similar to signaling lymphocytic activation molecule
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01390,184,545 - 90,219,170 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.013101,446,883 - 101,481,363 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41387,769,569 - 87,804,963 (+)NCBIRGSC3.4rn4RGSC3.4
Celera1383,882,850 - 83,917,969 (+)NCBICelera
Cytogenetic Map13q24NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Molecular Pathway Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Slamf1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1560634
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.